-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LwU0PW1PJH6M4ECWvHux/hch6zUySqUFW7SDHcAePRsf/h7SSSbKuOb5BdjeDxYN G0zWMgQbAs54Kd63VTcBNw== 0000000000-08-010306.txt : 20080414 0000000000-08-010306.hdr.sgml : 20080414 20080227151101 ACCESSION NUMBER: 0000000000-08-010306 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080227 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 PUBLIC REFERENCE ACCESSION NUMBER: 0001193125-07-054452 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C0Y(#`@;V)J#3P\+TQI;F5A-IB M8&#@9&!@D68``N'G#*B`"8A9&#@:D,4XH9B!09F!AW/"?2D!!J=?2;P,'$P+ M8'JD@Z!ZK8"8D8%!@@E",P?`36%C8-!>`!%EY``(,`#_=0?>#0IE;F1S=')E M86T-96YD;V)J#38P(#`@;V)J#3P\+TQE;F=T:"`R,"]&:6QT97(O1FQA=&5$ M96-O9&4O5ULQ(#$@,5TO26YD97A;-R`T,ETO1&5C;V1E4&%R;7,\/"]#;VQU M;6YS(#,O4')E9&EC=&]R(#$R/CXO4VEZ92`T.2]4>7!E+UA2968^/G-T-IB8F)D8&)@8!SL&"#``"O-`($-"F5N9'-T7!E+T%R='=O7!E+TA&/CX^/B].86UE*$AE861E%LP(#`@-C$R M(#'1'4W1A=&4\/"]'4S`@-3D@,"!2/CX^/B]4>7!E+U!A9V4^/@UE M;F1O8FH--3,@,"!O8FH-/#PO4W5B='EP92]43Q2BQ@;D?9,SS:D=Z>\J])RF62I6`/A]D/F(<$_`&UF.^&0%T/?->W MR&!`X?'=N^%X!+UAU+,_C<">C`CH!7LT(Q`70/07BCCMV7_@TM>B9T<1`0K1 MLL,:`_F/TH72;J!R5R:ER:S)Z M/\;+!R85.KE$)J'E*F#$B_XI86H8](A!P*06"2$:=YQD9R?=[J/.JT$'KP=U MVT`G/%G#3&(@/4))ZSWO=,\BA/@0Q6`>?^Z@;G=N?$DXW/*X2#;]T$C6`GBZ M@,_6S`)MJ`I(#=^O>"$TJ8%V^Q*TN_T_?1Y^Z]BX%4_YEN=[8/X5,$("Q4VG M2IFM[63#BNPIKW_J(24-V5DE.SN7W9CD%MQ9<)W*59;N892M10'MJ+2!.JA0 M!V>ZSXUI+HID(=*^:TB,(PX+&*T2L82;'R+>RN2[@$_+91)C5VB/+#VEO%DY MT>[#W+B;SF"ZXGG?](T-CP4:B/FZN(+W:6QU&7`:[M#*'7J>1D[@*&&R/-O! M.%?UL[EOL+F4V]IF;TI)EV MR5/WD62T0,GNQ1OHF]3QR*^I=U9Y:(3JP#C:B%L:N M0$_DC%O58NXR"XC)'.:SCCB$C9C2%WHD>[GJS+!F?(P"@"H]76]O:FVB%9E> M.A3]WD6#=>5U>!8?XV\!*X[9'&>;Y[60J'*VS2$7WQ.Q@VP)>S75;:K-(>I: M(3V%J19JE4_H.U9;G"BC<@/!B/LH0^N2TW' M?*J'-H+CYTWK5J_:N?LO?X)POS7OY:"*L>(#N4+"MW9P87Y=& MBA+H,!Q,'F:RG/%RIL/K'AG)9W5%37%H?/O7=ZH>_E MY??'O=_:9^]S]]E[G[4N`"1/'RXO!98"()DGX`=Z.--7A4?0L?T`!GB``:8` M,%GIJ;Y![L%`)"\W%WJZR`G\B]X,`4C\OF7HZ4^G@_]/TJQ4O@``R%_$YFQ. M.DO$^2).RA2DBNTS(J;&)(H91HF9+TI0Q')BCEODI9]]%ME1S.QD'EO$XIQ3 MV(>'N&D"-BQ$?$!1E<3J:(;XM8,TF8S!7Q6W%L,H>9#@"*)+8+.*QX M$9N(F,0/#G01\7(`<*2X+SCF"Q9PL@3B0[FDI&;SN7'Q`KHN2X]N:FW-H'MR M,I,X`H&A/Y.5R.2SZ2XIR:E,7C8`BV?^+!EQ;>FB(EN:6EM:&IH9F7Y1J/^Z M^#'[:_\4NH`8,R*:K/K#UO,?@`ZM@(@=_\/F^8A`"1% M?6N_\<5Y:.)YB1<(4FV,C3,S,XVX'):1N*"_ZW\Z_`U]\3TC\7:_EX?NRHEE M"I,$=''=6"E)*4(^/3V5R>+0#?\\Q/\X\*_S6!K(B>7P.3Q11*AHRKB\.%&[ M>6RN@)O"HW-Y_ZF)_S#L3UJ<:Y$H]9\`-5#<]=_[ MYH,/!>*;%Z8ZL3CWGP7]^ZYPB?B1SHW['.<2&$QG"?D9BVOB:PG0@``D`17( M`Q6@`72!(3`#5L`6.`(WL`+X@6`0#M8"%H@'R8`/,D$NV`P*0!'8!?:"2E`# MZD$C:`$G0`0A54@+,H#, M(`9D#[E!/E`@%`Y%0W$0#Q)"N=`6J`@JA2JA6J@1^A8Z!5V`KD(#T#UH%)J" M?H7>PPA,@JFP,JP-&\,,V`GVAH/A-7`WP!?@Z?`<> M@9_#LPA`B`@-44,,$0;B@O@A$4@LPDVH'M0MU"AJ!O4)348KH0W0-F@O]"IT M'#H378`N1S>@V]"7T'?0X^@W&`R&AM'!6&$\,>&8!,PZ3#'F`*85P@=AS[%D?$J>+,<.ZX"!P/EX;P47@MO@_?#L_'9^!)\/;X+?P,_CI\G2!-T"':$8$("83.A@M!" MN$1X2'A%)!+5B=;$`"*7N(E803Q.O$(<);XCR9#T22ZD2)*0M)-TA'2>=(_T MBDPF:Y,=R1%D`7DGN9%\D?R8_%:"(F$DX27!EM@H4271+C$H\4(2+ZDEZ22Y M5C)'LESRI.0-R6DIO)2VE(L44VJ#5)74*:EAJ5EIBK2IM)]TLG2Q=)/T5>E) M&:R,MHR;#%LF7^:PS$69,0I"T:"X4%B4+91ZRB7*.!5#U:%Z41.H1=1OJ/W4 M&5D9V66RH;)9LE6R9V1':`A-F^9%2Z*5T$[0AFCOER@O<5K"6;)C2"E?25`I76*1U6ZE.:5591]E!.5=ZO?%%Y6H6FXJB2H%*F>JOZ M(PV"!D,C5J-,HUMC1E-5TUYMVA_:D MCIR.ETZ.3K/.0UVRKH-NFFZ=[FT]C!Y#+U'O@-Y-?5C?0C]>OTK_A@%L8&G` M-3A@,+`4O=1Z*6]IW=)A0Y*ADV&&8;/AJ!'-R,OWS,3MV.:5=K-V)/MX^V/V0_XJ#FP'2H M_M7]'B3O(.\ M*[V?^.C[\'VZ?&'?%;Y[?!^NU%K)6]GA!_R\_/;X/?+7\4_S_SX`$^`?4!7P M--`T,#>P-X@2%!74%/0FV#FX)/A!B&Z(,*0[5#(T,K0Q="[,-:PT;&25\:KU MJZZ'*X1SPSLCL!&A$0T1LZO=5N]=/1YI$5D0.;1&9TW6FJMK%=8FK3T3)1G% MC#H9C8X.BVZ*_L#T8]8Q9V.\8JIC9E@NK'VLYVQ'=AE[BF/'*>5,Q-K%EL9. MQMG%[8F;BG>(+X^?YKIP*[DO$SP3:A+F$OT2CR0N)(4EM2;CDJ.33_%D>(F\ MGA25E*R4@52#U(+4D32;M+UI,WQO?D,ZE+XFO5-`%?U,]0EUA5N%HQGV&549 M;S-#,T]F26?QLOJR];-W9$_DN.=\O0ZUCK6N.U[TE;$M7OG+^IORQK1Y;FPLD"O@%P]ML MM]5L1VWG;N_?8;YC_XY/A>S":T4F1>5%'XI9Q=>^,OVJXJN%G;$[^TLL2P[N MPNSB[1K:[;#[:*ET:4[IV![?/>UE]++"LM=[H_9>+5]67K./L$^X;Z3"IZ)S MO^;^7?L_5,97WJERKFJM5JK>43UW@'U@\*#CP98:Y9JBFO>'N(?NUGK4MM=I MUY4?QAS../RT/K2^]VO&UXT-"@U%#1^/\(Z,'`T\VM-HU=C8I-14T@PW"YNG MCD4>N_F-ZS>=+88MM:VTUJ+CX+CP^+-OH[\=.N%]HOLDXV3+=UK?5;=1V@K; MH?;L]IF.^(Z1SO#.@5,K3G5WV7:U?6_T_9'3:J>KSLB>*3E+.)M_=N%]9_]O&;Y#?S M?<=XU_L^[/W$?.8'[(>*CWH?NSYY?WJXD+RP\)L``P#WA//["@T* M96YD2A4:6UE7!E+T]#340^/@UE;F1O8FH--3D@,"!O8FH-/#PO M3U!-(#$O3U`@9F%L'1'4W1A=&4O4T$@9F%L M%YN-UXA>L[_?>UP*;]+7MP\RHB`H2`J* M@J804T@H&`I$D4111%%$44111%%$44111%%$44111-%$T4311-%$T4311-%$ MT431GO*=GS&?\YSG=MGRXZ):?3R:?[[(/WSR>Y]WMYO+J/_2>KE_-:W6967S M'P6J-RE7G;/\T-7-N&AVZ6G7]A*>-T7%\^YJLW1ET^[2QKK'+Q:G(_S&^$U\ M1$/*G[;N=L/HWD%]QP_+7WQ>N]MBS<_X475=U:W%"_Q-T+>'[**ZMN[!'=1I MCYWRB2MNK<<\63KL24#;]0Z7@NHHJ(Z"ZBBHCB)Y*`4LEG9TTUK'HB^17^MH M7:XJ_K7;M.7-EI^BHMM^+]]P6AJ"-&!XZ/=T=\ MQB)<3>F?JVEW[EW\OVD&6[VX5H9H%4!6AV@C0.T28#6!&C3`&T6THN@ MQH5T3H2T3H3T3H0T3PSIGGK^.8LA?=0O9IG!LR!.0\1#>AH_7X^,!L^">$AS MDQ<67!E+UA-3"],96YG=&@@,SDX-R]4>7!E+TUE=&%D871A/CYS=')E86T- M"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZDY4 M8WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B M('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#0N,"UC,S$V(#0T+C(U,SDR,2P@ M4W5N($]C="`P,2`R,#`V(#$W.C$T.C,Y(CX*("`@/')D9CI21$8@>&UL;G,Z M&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q M+C,O(CX*("`@("`@("`@/'!D9CI0#I3;W5R8V5-;V1I9FEE9#X*("`@("`@ M/"]R9&8Z1&5S8W)I<'1I;VX^"B`@("`@(#QR9&8Z1&5S8W)I<'1I;VX@&%P.D-R96%T M941A=&4^,C`P."TP,BTR-U0Q-3HP.#HP-BTP-3HP,#PO>&%P.D-R96%T941A M=&4^"B`@("`@("`@(#QX87`Z365T861A=&%$871E/C(P,#@M,#(M,C=4,34Z M,#@Z,#DM,#4Z,#`\+WAA<#I-971A9&%T841A=&4^"B`@("`@(#PO&%P34TZ26YS=&%N8V5)1#YU=6ED M.F$P9&8S9&-B+6%A9F0M-#ED8BUA,F(Q+6(W83`P8F(Y,C(Y93PO>&%P34TZ M26YS=&%N8V5)1#X*("`@("`@("`@/'AA<$U-.G-U8FIE8W0^"B`@("`@("`@ M("`@(#QR9&8Z4V5Q/@H@("`@("`@("`@("`@("`\"UD969A=6QT(CY6:6$@ M1F%CF4@-#D^/@T* -----END PRIVACY-ENHANCED MESSAGE-----